Shares of Calumet, Inc. (NASDAQ:CLMT – Get Free Report) have been given an average recommendation of “Hold” by the eight research firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $22.8333.
A number of research analysts have recently commented on CLMT shares. Wall Street Zen lowered shares of Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. UBS Group reissued a “neutral” rating and set a $26.00 price objective on shares of Calumet in a research note on Friday, February 13th. HC Wainwright restated a “buy” rating and issued a $33.00 target price on shares of Calumet in a research note on Monday, November 10th. Finally, Zacks Research raised Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th.
Get Our Latest Research Report on CLMT
Institutional Investors Weigh In On Calumet
Calumet Trading Down 4.3%
CLMT stock opened at $28.14 on Friday. The firm has a 50 day moving average of $22.14 and a 200-day moving average of $19.41. Calumet has a 12 month low of $7.68 and a 12 month high of $29.92. The firm has a market capitalization of $2.44 billion, a P/E ratio of -65.44 and a beta of 1.24.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
See Also
- Five stocks we like better than Calumet
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
